DATA FALSIFICATION IN CLINICAL-TRIALS

This article uses an infamous case of data falsification in clinical r esearch as a starting point for a deeper analysis of some of the motiv ations and obligations that could encourage misconduct in a clinical s etting. The article argues that the use of alternative, less rigid exp erimental designs and protocols could help lessen the pressures on res earchers to falsify clinical data pertaining to patient records, and t hat it is worth considering alternative designs to benefit patients an d help promote integrity in medical research.